Features of the methodology for calculating the tuberculosis screening coverage rate for children in a megalopolis

Introduction. The paediatric tuberculosis screening coverage rate can vary significantly depending on its calculation and planning methodology, which will ultimately affect the formation of rates in the reporting period.

Aim. To review the results of annual immunological screening and the methodology for calculating the preventive tuberculosis screening coverage rates for the metropolitan population aged 1–17 years.

Materials and methods. The data from 2023 healthcare facility reports on preventive screening of children aged 1–17 years in Moscow using a skin test with purified tuberculosis allergen-standard solution and a skin test using recombinant tuberculosis allergen-standard solution were used.

Results. In accordance with the 2023 population screening program for early detection of tuberculosis in Moscow, the number of children screened for tuberculosis using immunoassay tests amounted to 1,900,739 (96.4% coverage of the assigned population). According to the data of Federal Statistical Monitoring (FSN) Form No. 30, 1,921,590 children (including 718,272 children aged 1–7 years) were screened for early detection of tuberculosis in Moscow healthcare facilities in 2023 (97.5% coverage rate against the program target), and 1,916,255 children were screened in healthcare facilities with assigned population (97.2% coverage rate against the program target). The preventive pediatric tuberculosis screening made it possible to identify 45 new cases of tuberculosis among children and adolescents, 86 new cases of residual post-tuberculosis changes, and also to form a high-risk group among children with altered tuberculosis allergen sensitivity (3,772).

Conclusions. The paediatric tuberculosis screening coverage rate depends on its calculation methodology; it should be planned and calculated based on the number of the assigned population to be served by healthcare facilities.

1. Аксенова ВА, Барышникова ЛА, Клевно НИ. Скрининговое обследование детей и подростков с целью выявления туберкулезной инфекции. 2018. 39 с. Режим доступа: https://pediatr-club.ru/upload/iblock/b1b/b1b561bc188c18b117ec2f73eeaad2d2.PDF.

2. Аksenova VA, Baryshnikova LA, Klevno NI, Kudlay DA. Screening for tuberculosis infection in children and adolescents in Russia – past, present, future. Tuberculosis and Lung Diseases. 2019;97(9):59–67. (In Russ.) https://doi.org/10.21292/2075-1230-2019-97-9-59-67.

3. Kulikov AY, Zinchuk IY, Protsenko MV, Krysanov IS. Diaskintest® for tuberculosis screening in children and adolescents: pricing policy and cost-effectiveness analysis. Tuberculosis and Lung Diseases. 2009;(9):41–46. (In Russ.) Available at: http://elib.fesmu.ru/Article.aspx?id=209421.

4. Chugaev YuP, Kamayeva NG, Tsvetkov AI, Kudlay DA, Cherniaev IA. Innovative technologies for detecting and diagnostic of tuberculosis in children and adolescents: achievements and problems. Pediatriya – Zhurnal im G.N. Speranskogo. 2020;99(6):112–118. (In Russ.) Available at: https://pediatriajournal.ru/archive?show=379§ion=6057.

5. Wang Z, Dendukuri N, Pai M, Joseph L. Taking Costs and Diagnostic Test Accuracy into Account When Designing Prevalence Studies: An Application to Childhood Tuberculosis Prevalence. Med Decis Making. 2017;37(8):922–929. https://doi.org/10.1177/0272989X17713456.

6. Levi DT, Obukhov YI, Rukhamina ML, Alexandrova NV, Nakonechnaya AV. Use of tuberculosis allergens for studying virulence antigens in Mycobacterium bovis strains. Biopreparaty. Profilaktika, Diagnostika, Lečenie. 2013;(1):23–27. (In Russ.) Available at: https://www.elibrary.ru/plhlsi.

7. Slogotskaya LV, Bogorodskaya EM, Shamuratova LF, Sevostyanova TA. Evaluation of effectiveness of mass screening for tuberculosis infection in children from 1 to 7 years old in Moscow. Tuberculosis and Lung Diseases. 2021;99(12):14–21. (In Russ.) https://doi.org/10.21292/2075-1230-2021-99-12-14-21.

8. Kudlay DA, Doktorova NP. ESAT-6 and CFP-10 antigens as a biotechnology molecule substrate. Applications in medicine. Russian Journal of Infection and Immunity. 2022;12(3):439–449. (In Russ.) http://doi.org/10.15789/2220-7619-EAC-1763.

9. Starshinova A, Dovgalyk I, Malkova A, Zinchenko Y, Pavlova M, Belyaeva E et al. Recombinant tuberculosis allergen (Diaskintest®) in tuberculosis diagnostic in Russia (meta-analysis). Int J Mycobacteriol. 2020;9(4):335–346. http://doi.org/10.4103/ijmy.ijmy_131_20.

10. Slogotskaya LV, Bogorodskaya Е, Ivanova D, Makarova M, Guntupova L, Litvinov V et al. Sensitivity and specificity of new skin test with recombinant protein CFP10-ESAT6 in patients with tuberculosis and individuals with non-tuberculosis diseases. Eur Respir J. 2013;42(Suppl. 57):1995. Available at: https://publications.ersnet.org/content/erj/42/suppl57/1995.

11. Богородская ЕМ (ред.). Эпидемиология, профилактика и лечение туберкулеза в г. Москве, 2022 г. М.: МНПЦБТ; 2023. 294 с.

12. Аксенова ВА, Барышникова ЛА, Бармина НА, Баронова ОД, Васильева ИА, Валиев РШ и др. Латентная туберкулезная инфекция у детей: клинические рекомендации. М.; 2024. 68 с. Режим доступа: https://rof-tb.ru/upload/iblock/bea/ipyds1oripuudoozu7v24gt7d3bmf16v.pdf.

13. Slogotskaya L, Bogorodskaya E, Ivanova D, Sevostyanova T. Comparative sensitivity of the test with tuberculosis recombinant allergen, containing ESAT6-CFP10 protein, and Mantoux test with 2 TU PPD-L in newly diagnosed tuberculosis children and adolescents in Moscow. PLoS ONE. 2018;13(12):e0208705. https://doi.org/10.1371/journal.pone.0208705.

14. Slogotskaya LV, Bogorodskaya EM, Shamuratova LF, Sevostyanova TA. Efficiency of screening for tuberculosis infection in children and adolescents in Moscow in 2019 based on the new procedure for using the intradermal test with tuberculosis recombinant allergen (ESAT-6/CFP-10). Tuberculosis and Lung Diseases. 2021;99(1):15–25. (In Russ.) https://doi.org/10.21292/2075-1230-2021-99-1-15-25.

15. Aksenova VA, Vasilyeva IA, Kasaeva TC, Samoilova AG, Pshenichnaya NY, Tyulkova TE. Latent tuberculosis infection in children and adolescents in Russia. Int J Infect Dis. 2020;92(Suppl.):26–30. https://doi.org/10.1016/j.ijid.2020.02.038.

16. Васильева ИА, Стерликов СА, Тестов ВВ, Михайлова ЮВ, Голубев ИА, Кучерявая ДА, Пономарев СБ. Ресурсы и деятельность противотуберкулезных организаций Российской Федерации в 2022–2023 гг. М.: РИО ЦНИИОИЗ; 2024. 95 с. Режим доступа: https://tubdisp-bel.belzdrav.ru/upload/iblock/fd3/Ресурсы%20и%20деятельность.pdf.